PI5P4Kα promotes glucose and iron acquisition to support metabolic fitness in pancreatic cancer

Phosphoinositide kinases generate distinct phosphoinositides that regulate pathways to support tumorigenesis. Phosphatidylinositol 5-phosphate 4-kinases (PI5P4Ks) have garnered interest for their role in cancer metabolism; however, their function in pancreatic ductal adenocarcinoma (PDAC) remains unexplored. We identify PI5P4Kα as a critical dependency to support the unique metabolic demands of PDAC cells through its key role in the acquisition of essential metabolic substrates, including glucose and iron. Our data show that inhibition of PI5P4Kα creates a metabolic bottleneck that PDAC cells cannot overcome through adaptive shifts, leading to cancer-specific apoptotic cell death that is reversible by iron supplementation. Notably, we find that PI5P4Kα knockdown suppresses tumor growth in a xenograft mouse model of PDAC. These results not only illuminate the mechanistic underpinnings of PI5P4Kα function in PDAC but also position it as a promising therapeutic target for this disease.

Authors

Institutions

Publication Details

Journal
Cell Reports
Published
2025-08-29
DOI
https://doi.org/10.1016/j.celrep.2025.116199
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PI5P4Kα promotes glucose and iron acquisition to support metabolic fitness in pancreatic cancer

David A. Scott, Shea Grenier, Cheska Marie Galapate, Rabi Murad et al.
Cell Reports
Pancreatic and Hepatic Oncology Research
article

PI5P4Kα promotes glucose and iron acquisition to support metabolic fitness in pancreatic cancer

David A. Scott, Shea Grenier, Cheska Marie Galapate, Rabi Murad, Alicia Llorente Lope, Yoav Altman, Ryan M. Loughran, Brooke M. Emerling, Gurpreet K. Arora, C. Zhang, Chantal Pauli, Guillem Lambies, Taylor Anderson, Sophia Crabtree, Cosimo Commisso, Kyanh Ly, Ling Li, B Portillo
article en

Abstract

Phosphoinositide kinases generate distinct phosphoinositides that regulate pathways to support tumorigenesis. Phosphatidylinositol 5-phosphate 4-kinases (PI5P4Ks) have garnered interest for their role in cancer metabolism; however, their function in pancreatic ductal adenocarcinoma (PDAC) remains unexplored. We identify PI5P4Kα as a critical dependency to support the unique metabolic demands of PDAC cells through its key role in the acquisition of essential metabolic substrates, including glucose and iron. Our data show that inhibition of PI5P4Kα creates a metabolic bottleneck that PDAC cells cannot overcome through adaptive shifts, leading to cancer-specific apoptotic cell death that is reversible by iron supplementation. Notably, we find that PI5P4Kα knockdown suppresses tumor growth in a xenograft mouse model of PDAC. These results not only illuminate the mechanistic underpinnings of PI5P4Kα function in PDAC but also position it as a promising therapeutic target for this disease.

Cell ReportsVol. 44(9)
Sanford Burnham Prebys Medical Discovery Institute (US), Discovery Institute (US), University Hospital of Zurich (CH)
American Cancer Society, National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences, Basic Research Laboratory
Zero hunger
Openalex Percentile: Top 68%
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.